Viewing nowLipostar 20 mg Tablets (Simvastatin)
Simvastatin 20mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

MFDS item code 200400828 · Notified 2004.06.18 · Insurance code 640900330
Improvement of hyperlipidemia and familial hypercholesterolemia in children; prevention of cardiovascular disease
This medication reduces the risk of cardiovascular disease. It particularly decreases the risk of death caused by coronary heart disease and the risk of non-fatal myocardial infarction and stroke in adult patients with a history of coronary heart disease, diabetes, peripheral vascular disease, and stroke. Additionally, it helps to lower the risk of complications after vascular interventions, facilitating safer treatment. For patients with hyperlipidemia, it decreases total cholesterol, LDL-cholesterol, Apo-B protein, and triglyceride levels, while increasing HDL-cholesterol to improve serum lipid levels. It is specifically used to treat familial hypercholesterolemia and various dyslipidemias and acts as an adjunct to diet in certain pediatric patients with hypercholesterolemia. Overall, it is used to protect cardiovascular health and effectively treat dyslipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication. 1. Reduction of the risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is simvastatin 40 mg once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medication once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medication. The recommended dose is 5 ~ 40 mg of this medication once daily in the evening. Before starting treatment, adjust the dose as appropriate based on the initial LDL cholesterol level, treatment goal, and the patient's response to the medication. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if cholesterol levels fall below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this medication should be used only in patients who have been taking 80 mg of this medication for 12 months or longer without evidence of muscle toxicity, particularly during the first year of treatment (see 1. Warnings under Precautions for Use). 2) Refer below for the recommended doses in patients receiving this medication concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient populations (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Drug Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this medication once daily in the evening. This medication should be used in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In elderly patients, a daily dose of 20 mg of this medication may achieve the maximum reduction in cholesterol levels. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this medication is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medication must not exceed 10 mg daily. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this medication is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medication must not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This medication is effective when used alone or in combination with a bile acid sequestrant. When this medication is coadministered with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medication must not exceed 10 mg daily. (6) Use in patients with renal impairment Because this medication is not substantially excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, the initial dose should be 5 mg daily, with careful monitoring.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily, administered in the evening. The recommended dosage range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily.
This medication can cause serious muscle-related side effects such as myopathy and rhabdomyolysis. The risk may be increased when taken in high doses or with certain medications, so caution is advised. Patients with hypersensitivity to this medication or its components, active liver disease, or unexplained elevated liver enzyme levels, as well as women who are pregnant or breastfeeding, should not use this medication. Additionally, caution is required for patients with impaired liver function, alcohol abuse, renal dysfunction, hypothyroidism, hereditary muscle disorders, the elderly, and women, and regular monitoring may be necessary. If symptoms such as muscle pain, weakness, or tenderness occur during treatment, the patient should consult a doctor immediately and discontinue medication in severe cases. Regular liver function tests should be performed as liver function abnormalities may develop, and any unusual signs should be reported to a doctor. This medication can interact with various drugs, so patients taking other medications should inform their healthcare provider, especially when used in conjunction with certain antifungals, antibiotics, immunosuppressants, calcium channel blockers, etc. This medication should not be used during pregnancy, and women of childbearing potential must use contraception while taking it. Breastfeeding women should discontinue breastfeeding if they take this medication. In children and adolescents, it should only be used with restrictions in cases aged 10 years and older, and doses above 40 mg are not recommended. In the event of an overdose, visit a medical institution for appropriate treatment, and this medication should be stored out of reach of children. Keep the medication in the original container, and do not transfer it to another container for safety.
Myopathy, rhabdomyolysis, abdominal pain, weakness, constipation, diarrhea, indigestion, bloating, nausea, headache, upper respiratory tract infection, edema, atrial fibrillation, gastritis, diabetes mellitus, myalgia, insomnia, dizziness, bronchitis, sinusitis, eczema, urinary tract infection, immune-mediated necrotizing myopathy, specific cranial nerve dysfunction, dysgeusia, abnormal ocular motility, facial incomplete paralysis, tremor, sensory disturbance, peripheral neuropathy, peripheral nerve paralysis, mental disorder, anxiety, sleep disorder, nightmares, depression, cognitive impairment, myasthenia gravis, oculomotor weakness, hepatitis, liver dysfunction, jaundice, pancreatitis, liver failure, cholestatic jaundice, hepatic steatosis, cirrhosis, fulminant hepatic necrosis, hepatocellular carcinoma, anorexia, vomiting, alopecia, pruritus, skin changes, lichen planus-like drug eruption, gynecomastia, decreased libido, sexual dysfunction, cataract progression, ophthalmoplegia, anemia, elevated aminotransferases, increased ALP, elevated γ-GTP, increased bilirubin levels, thyroid dysfunction, elevated serum creatine kinase, abnormal liver function tests, increased HbA1c, increased fasting blood glucose levels, sensory numbness in the limbs, paresthesia, cold sensation, thrombocytopenia, lupus erythematosus-like syndrome, vasculitis, purpura, thrombocytopenia, leukopenia, hemolytic anemia, positive antinuclear antibodies, increased erythrocyte sedimentation rate, eosinophilia, arthritis, arthralgia, urticaria, photosensitivity, fever, chills, flushing, malaise, dyspnea, toxic epidermal necrolysis, mucocutaneous syndrome, erythema multiforme, interstitial lung disease, myoglobinuria, acute kidney injury, optic nerve degeneration, perivascular hemorrhage, perivascular edema, perivascular mononuclear cell infiltration, perivascular fibrin deposition, small vessel necrosis, vestibular labyrinth Wallerian-like degeneration, retinal ganglion cell chromatin lysis, perivascular hemorrhage, perivascular edema, perivascular mononuclear cell infiltration, perivascular fibrin deposition, small vessel necrosis, cataract, testicular atrophy, decreased spermatogenesis, giant cell formation
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. Additionally, it should be kept at room temperature, ideally between 1 and 30 degrees Celsius. Storing it this way will help maintain the safety and efficacy of the medication.
Brownish yellow oval film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 20mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.